Gilead preps new 500-employee plant near current San Dimas site

Gilead Sciences ($GILD) is plotting a new, 400,000-square-foot manufacturing site near its current plant in San Dimas, CA, local media reports, saying the facility will employ 500 people. The new production site in La Verne is said to replace San Dimas, which has suffered under FDA scrutiny in the past. Report

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.